Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.

referredUnited States· United States Congress· EN

Introduced

5 February 2015

Last action

—

Status

Referred to the Subcommittee on Health.

Summary

Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in House (text)

View file Download file

Introduced in House (text)
Introduced in House · EN · 5 February 2015
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 5 February 2015
View Download Open at official source
Introduced in House
summary · EN · 5 February 2015
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/114th-congress/house-resolution/95
Open data entity: https://api.congress.gov/v3/bill/114/hres/95